Key statistics
On Friday, Arcturus Therapeutics Holdings Inc (ARCT:NMQ) closed at 19.63, 13.70% above the 52 week low of 17.26 set on Nov 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 19.50 |
---|---|
High | 19.93 |
Low | 18.81 |
Bid | 19.01 |
Offer | 19.83 |
Previous close | 18.74 |
Average volume | 350.81k |
---|---|
Shares outstanding | 27.04m |
Free float | 24.71m |
P/E (TTM) | -- |
Market cap | 530.70m USD |
EPS (TTM) | -2.33 USD |
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
- Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress
- Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024
- Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination
- Japan’s Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics’ Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma
- Arcturus Therapeutics Receives Clearance of an Investigational New Drug Application to U.S. Food and Drug Administration for ARCT-032, an Investigational Inhaled mRNA Therapeutic to Treat Cystic Fibrosis
- Arcturus Therapeutics to Attend Upcoming Investor & Scientific Conferences
More ▼